First Horizon Advisors, Inc. Bio Rad Laboratories, Inc. Transaction History
First Horizon Advisors, Inc.
- $3.28 Billion
- Q2 2024
A detailed history of First Horizon Advisors, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 271 shares of BIO stock, worth $89,056. This represents 0.0% of its overall portfolio holdings.
Number of Shares
271
Previous 400
32.25%
Holding current value
$89,056
Previous $138,000
46.38%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding BIO
# of Institutions
459Shares Held
19.6MCall Options Held
23.2KPut Options Held
37.4K-
Vanguard Group Inc Valley Forge, PA2.37MShares$780 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$510 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$428 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$357 Million3.03% of portfolio
-
State Street Corp Boston, MA860KShares$283 Million0.01% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.1B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...